Clinical Trial: Study of the Effects of an Oral Nitric Oxide Supplement on Blood Pressure in Prehypertensive Adults

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Study of the Effects of an Oral Nitric Oxide Supplement on Functional Capacity and Blood Pressure in Healthy Adults With Prehypertension

Brief Summary: Oral supplementation of Neo40(TM), a nitrate lozenge, will reduce blood pressure in healthy adults with clinical prehypertension.

Detailed Summary:
Sponsor: Neogenis Laboratories

Current Primary Outcome: Reduction in Systolic and Diastolic Blood Pressure Readings [ Time Frame: 30 days ]

Two blood pressure readings at rest will be taken at baseline and again after thirty days during the follow-up appointment.


Original Primary Outcome: Same as current

Current Secondary Outcome: Improvement in Functional Capacity [ Time Frame: 30 days ]

Participant will take a six minute walk test at baseline and again after thirty days during the follow-up appointment. Achieved distances will be measured and recorded.


Original Secondary Outcome: Same as current

Information By: Neogenis Laboratories

Dates:
Date Received: August 29, 2013
Date Started: January 2013
Date Completion:
Last Updated: September 4, 2013
Last Verified: September 2013